Melin Jonas, Jarvius Jonas, Larsson Chatarina, Söderberg Ola, Landegren Ulf, Nilsson Mats
Department of Genetics and Pathology, Rudbeck Laboratory, University of Uppsala, SE 75185 Uppsala, Sweden.
N Biotechnol. 2008 Jun;25(1):42-8. doi: 10.1016/j.nbt.2008.02.003. Epub 2008 May 1.
Molecular diagnostics can offer early detection of disease, improved diagnostic accuracy, and qualified follow-up. Moreover, the use of microfluidic devices can in principle render these analyses quickly and user-friendly, placing them within the reach of the general practitioner and maybe even in households. However, the progress launching such devices has been limited so far. We propose that an important limiting factor has been the difficulty of establishing molecular assays suitable for microfabricated formats. The assays should be capable of monitoring a wide range of molecules, including genomic DNA, RNA and proteins with secondary modifications and interaction partners, and they must exhibit excellent sensitivity and specificity. We discuss these problems and describe a series of molecular tools that may present new opportunities for lab-on-a-chip devices at the point-of-care.
分子诊断能够实现疾病的早期检测、提高诊断准确性并进行有效的随访。此外,从原理上讲,使用微流控设备可以使这些分析快速且便于用户操作,让普通医生甚至家庭都能够进行。然而,到目前为止,推出此类设备的进展有限。我们认为一个重要的限制因素是难以建立适用于微制造形式的分子检测方法。这些检测方法应能够监测广泛的分子,包括基因组DNA、RNA以及具有二级修饰和相互作用伙伴的蛋白质,并且必须具有出色的灵敏度和特异性。我们讨论了这些问题,并描述了一系列分子工具,这些工具可能为即时医疗的芯片实验室设备带来新的机遇。